查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466677

微流体市场：按材料、组件、应用和最终用户划分 - 2024-2030 年全球预测

Microfluidics Market by Material (Glass-based, Polymer-based, Silicon-based), Component (Micro Needle, Micro Pump, Microfluidic Chip), Application, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年微流体市场规模为255.3亿美元，预计2024年将达318.4亿美元，2030年将达1243.1亿美元，复合年增长率为25.37%。

微流体是一个跨学科的科学领域，涉及微尺度（通常从微升到皮升）流体的精确控制、操作和分析。微流体整合了物理、工程、化学和生物学等各个领域的原理，有助于使用具有数十至数百微米。全球生命科学研究投资的增加正在加速对创新工具和技术的需求。微流体装置具有高通量筛检能力和小体积流体处理的精确控制等优点，使其成为对研究人员有吸引力的工具。以精准医疗为重点的医疗保健基础设施的进步也有助于微流体技术越来越多地采用用于诊断目的。然而，设计、製造和将微流体装置整合到目前实验室工作流程中所涉及的复杂性，以及不同製造方法带来的标准化问题，极大地阻碍了微流体的使用。製造商正在专注于开发穿戴式诊断设备，利用微流体技术即时监测患者健康状况。

主要市场统计
基准年[2023] 255.3亿美元
预测年份 [2024] 318.4亿美元
预测年份 [2030] 1243.1亿美元
复合年增长率（%） 25.37%

材料：微流体装置更多使用玻璃和硅基材料

玻璃因其优异的光学透明性、高耐化学性和生物相容性而成为微流体装置的首选。基于聚合物的微流体装置具有製造成本较低、技术製造容易和设计灵活性等优点。硅广泛应用于微电子领域，是整合感测器、致动器和其他电子机械系统 (MEMS) 组件的理想选择。硅基微流体具有尺寸精度高、表面粗糙度低以及与标准半导体製造流程相容等优点。

组成部分：透过使用微针和帮浦将感染风险降至最低

微针是用于各种医疗应用的微创设备，包括药物输送、疫苗接种和诊断。与传统的皮下注射针相比，微针因其无痛给药、感染风险最小以及组织损伤减少而成为基于需求的偏好。微型泵浦在微流体中至关重要，它允许在微尺度上传输、计量和混合流体。微流体晶片是微流体系统的支柱，能够整合各种组件来执行复杂的流体操纵任务。

应用：微流体装置在体外诊断与治疗的重要应用

体外诊断 (IVD) 透过提供疾病检测、预防和管理讯息，在医疗保健系统中发挥重要作用。微流体由于能够操纵少量液体，允许快速分析并提高诊断分析的灵敏度，从而彻底改变了 IVD。微流体在简化药物和生命科学研究方法（例如药物发现、细胞生物学研究、基因组/蛋白质组分析和合成生物学应用）方面具有巨大潜力。使用微流体平台的优点是减少试剂消费量、更快的反应时间、精确控制实验条件以及在单一晶片/平台上整合多种功能。微流体具有透过药物传输系统、个人化医疗、再生医学和组织工程的创新来彻底改变治疗方法的巨大潜力。在微尺度上特异性控制流体流动的能力使得能够开发针对特定细胞和组织的新治疗解决方案，从而减少与全身给药相关的副作用。

最终用户：研究机构、医院和诊断中心微流体的新用例

学术和研究机构正在将微流体用于生物科学、材料科学和化学工程实验。这些最终用户需要精确控制流体、结果的高再现性以及减少样品体积。医院和诊断机构正在透过需要快速分析体液中的生物标记和其他分析物的照护现场(POC) 诊断从微流体技术中受益。微流体正在彻底改变製药和生物技术产业的药物开发和製造流程。

区域洞察

在美洲，美国和加拿大已成为微流体市场的主要参与者。美国国立卫生研究院 (NIH) 正在大力投资微流体研究，以推进个人化医疗并开发创新的诊断解决方案。中国、日本和印度等国家在亚太地区展现出微流体的巨大成长潜力。在中国，许多在政府支持下的研究机构正致力于开发新的微流体平台，用于临床诊断和环境监测等应用。欧盟（EU）国家为微流体技术的发展做出了巨大贡献，许多学术机构与工业界密切合作以实现商业化。在中东和非洲地区，人们对采用尖端医疗技术（包括微流体）用于诊断目的越来越感兴趣。沙乌地阿拉伯和阿拉伯联合大公国等国家正在投资最先进的医疗设施，这些设施利用实验室晶片系统等先进工具来帮助更快地检测疾病。

FPNV定位矩阵

FPNV定位矩阵对于评估微流体市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对微流体市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.微流体市场的市场规模与预测是多少？

2.微流体市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些？

3.微流体市场的技术趋势与法规结构是什么？

4.微流体市场主要厂商的市场占有率为何？

5. 进入微流体市场的合适形式和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病的增加和对就地检验的需求
      • 微流体晶片的小型化提高了设备的便携性并缩短了分析週转时间
      • 使用微流体进行药物传输的潜在应用
    • 抑制因素
      • 复杂而漫长的监管核准流程
    • 机会
      • 开发基于微流体的 3D 细胞培养系统，例如器官晶片
      • 用于生物医学分析和诊断的微流体组件的进展
    • 任务
      • 微流体与现有工作流程的集成
  • 市场区隔分析
    • 材料：微流体装置中玻璃和硅基材料的使用增加
    • 组成部分：采用微针和帮浦以最大限度地降低感染风险
    • 应用：微流体装置在 IVD 与治疗上的重要应用
    • 最终使用者：微流体在研究机构、医院和诊断中心的新用途
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析
  • 客户客製化

第六章微流体市场：依材料分类

  • 玻璃底座
  • 聚合物基
  • 硅胶底座

第七章微流体市场：依组成部分

  • 微型针
  • 微型帮浦
  • 微流体晶片

第八章微流体市场：依应用分类

  • 体外诊断
  • 製药与生命科学研究
  • 治疗药物

第 9 章微流体市场：依最终用户分类

  • 学术研究所
  • 医院和诊断中心
  • 製药和生物技术公司

第十章美洲微流体市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区微流体市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲微流体市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 市场占有率分析（2023）
  • FPNV定位矩阵（2023）
  • 竞争场景分析
    • Astraveus 在种子轮融资中筹集了 1,650 万欧元，以推进自动化微流体细胞和基因治疗製造平台的开发
    • Bio-Techne 将收购瑞士空间生物学公司 Lunaphor
    • CellFE 宣布在 ASGCT 2023 年会上展示新的微流体细胞工程平台

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-036C5CF3A81A

[183 Pages Report] The Microfluidics Market size was estimated at USD 25.53 billion in 2023 and expected to reach USD 31.84 billion in 2024, at a CAGR 25.37% to reach USD 124.31 billion by 2030.

Microfluidics is a multidisciplinary scientific field that deals with the precise control, manipulation, and analysis of fluids at a microscale level, typically in microliters to picoliters. Microfluidics integrates principles from diverse disciplines such as physics, engineering, chemistry, and biology to facilitate operations on small volumes of fluids using microfabricated devices featuring channels with dimensions ranging from tens to hundreds of micrometers. Increasing global investments in life sciences research have accelerated the demand for innovative tools and technologies. Microfluidic devices offer advantages such as high throughput screening capabilities and precise control over fluid handling at low volumes, making them attractive tools for researchers. Advances in healthcare infrastructure focusing on precision medicine have also contributed to an increased adoption of microfluidic technologies for diagnostic purposes. However, the complexity associated with designing, fabricating, and integrating microfluidic devices into current laboratory workflows and standardization issues arising due to different fabrication methods significantly impedes the usage of microfluidics. In addition, manufacturers focus on developing wearable diagnostic devices that employ microfluidic technologies to monitor patients' health in real-time.

KEY MARKET STATISTICS
Base Year [2023] USD 25.53 billion
Estimated Year [2024] USD 31.84 billion
Forecast Year [2030] USD 124.31 billion
CAGR (%) 25.37%

Material: Increasing use of glass and silicon-based materials for microfluidic devices

Glass is preferred for microfluidic devices due to its excellent optical transparency properties, high chemical resistance, and biocompatibility. Polymer-based microfluidic devices offer advantages such as lower manufacturing costs, ease of fabrication through techniques, and flexibility in design. Silicon is widely used in microelectronics and is ideal for integrating sensors, actuators, and other microelectromechanical systems (MEMS) components. Silicon-based microfluidics offer advantages such as high dimensional accuracy, low surface roughness, and compatibility with standard semiconductor fabrication processes.

Component: Adoption of microneedles and pumps for minimal risk of infection

Microneedles are minimally invasive devices for various medical applications such as drug delivery, vaccination, and diagnostics. The need-based preference for microneedles is driven by painless drug administration, minimal risk of infection, and reduced tissue damage compared to traditional hypodermic needles. Micropumps are essential in microfluidics, enabling fluid transportation, metering, and mixing at the microscale. Microfluidic chips are the backbone of microfluidic systems, enabling the integration of various components to perform complex fluid manipulation tasks.

Application: Significant application of microfluidic devices in IVD and therapeutics

In-vitro diagnostics (IVD) play a crucial role in healthcare systems by providing information for disease detection, prevention, and management. Microfluidics has revolutionized IVD by enabling rapid analyses and enhanced sensitivity in diagnostic assays with its ability to manipulate small volumes of fluid. Microfluidics has immense potential to streamline pharmaceutical and life science research processes such as drug discovery, cell biology studies, genomics/proteomics analysis, and synthetic biology applications. The advantages of using microfluidic platforms are reduced reagent consumption, faster reaction times, precise control over experimental conditions, and integration of multiple functionalities on a single chip/platform. Microfluidics holds significant potential to revolutionize therapeutics through innovations in drug delivery systems, personalized medicine, regenerative medicine, and tissue engineering. The ability to specifically control fluid flow at the microscale enables the development of novel therapeutic solutions targeting specific cells or tissues, reducing side effects associated with systemic administration.

End User: Emerging use of microfluidics in research organizations and hospitals & diagnostics centers

Academic institutions and research organizations rely on microfluidics to conduct biosciences, material sciences, and chemical engineering experiments. These end users require precise control over fluids, high reproducibility of results, and reduced sample volume consumption. Hospitals and diagnostic facilities benefit from microfluidic technology through point-of-care (POC) diagnostics requiring rapid analysis of biomarkers or other analytes in body fluids. Microfluidics is revolutionizing drug development and manufacturing processes within the pharmaceutical and biotechnology industries.

Regional Insights

In the Americas, the United States and Canada emerged as key players in the microfluidics market due to their robust healthcare infrastructure and strong focus on research, which has led to increased investment from the public and private sectors. The National Institutes of Health (NIH) invests heavily in microfluidics research to advance personalized medicine and develop innovative diagnostic solutions. Countries such as China, Japan, and India showcase immense growth potential in microfluidics in the Asia-Pacific region. In China, numerous research institutions backed by government initiatives focus on developing novel microfluidic platforms for applications such as clinical diagnostics and environmental monitoring. European Union (EU) countries contribute significantly to developing microfluidics technologies, with numerous academic institutions working closely with industries for commercialization. The MEA region is developing interest in adopting cutting-edge medical technologies, including microfluidics, for diagnostic purposes. Countries, including Saudi Arabia and the UAE, have invested in state-of-the-art healthcare facilities that utilize advanced tools such as lab-on-a-chip systems for rapid disease detection.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Microfluidics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Microfluidics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Microfluidics Market, highlighting leading vendors and their innovative profiles. These include Abaxis, Inc., Abbott Laboratories, AbCellera Biologics Inc., Achira Labs Pvt. Ltd., Agilent Technologies, Inc., Ascent Bio-Nano Technologies, Inc., Bio-Rad Laboratories, Inc., BioFluidica, Biosurfit SA, Camozzi Automation S.p.A., Cellix Limited, Danaher Corporation, Dolomite Microfluidics, Elvesys Group, Fluidigm Corporation by Standard BioTools Inc., Fluigent S.A., Idex Corporation, Illumina, Inc., IMT Masks and Divisions AG, Koninklijke Philips N.V., Micropoint Bioscience, Inc., Mission Bio, Inc., NanoCellect Biomedical., OPKO Health, Inc., Parker-Hannifin Corporation, PerkinElmer Inc., Quidel Corporation, SMC Corporation, Sphere Fluidics Limited, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Microfluidics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Material
    • Glass-based
    • Polymer-based
    • Silicon-based
  • Component
    • Micro Needle
    • Micro Pump
    • Microfluidic Chip
  • Application
    • In-Vitro Diagnostics
      • Clinical Diagnostics
      • Point-Of-Care Testing
      • Veterinary Diagnostics
    • Pharmaceutical & Life Science Research
      • Lab Analytics
        • Capillary Electrophoresis
        • Cell-based Assays
        • Genomic analysis
        • Proteomic Analysis
      • Microdispensing
      • Microreaction
    • Therapeutics
      • Drug Delivery
      • Wearable Devices
  • End User
    • Academic & Research Institutes
    • Hospitals & Diagnostic Centers
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Microfluidics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Microfluidics Market?

3. What are the technology trends and regulatory frameworks in the Microfluidics Market?

4. What is the market share of the leading vendors in the Microfluidics Market?

5. Which modes and strategic moves are suitable for entering the Microfluidics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Incidence of Chronic Diseases and Increasing Demand for Point-Of-Care Testing
      • 5.1.1.2. Improved Portability of Devices through Microfluidic Chip Miniaturization and Faster Turn-Around Time for Analysis
      • 5.1.1.3. Potential Applications of Drug Delivery using Microfluidics
    • 5.1.2. Restraints
      • 5.1.2.1. Complicated and Time-Consuming Regulatory Approval Process
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of Microfluidic-Based 3D Cell Culture Systems such as Organ-on-a-Chip
      • 5.1.3.2. Advances in Microfluidic Components for Biomedical Analysis and Diagnostics
    • 5.1.4. Challenges
      • 5.1.4.1. Integration of Microfluidics with Existing Workflows
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Material: Increasing use of glass and silicon-based materials for microfluidic devices
    • 5.2.2. Component: Adoption of microneedles and pumps for minimal risk of infection
    • 5.2.3. Application: Significant application of microfluidic devices in IVD and therapeutics
    • 5.2.4. End User: Emerging use of microfluidics in research organizations and hospitals & diagnostics centers
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis
  • 5.8. Client Customization

6. Microfluidics Market, by Material

  • 6.1. Introduction
  • 6.2. Glass-based
  • 6.3. Polymer-based
  • 6.4. Silicon-based

7. Microfluidics Market, by Component

  • 7.1. Introduction
  • 7.2. Micro Needle
  • 7.3. Micro Pump
  • 7.4. Microfluidic Chip

8. Microfluidics Market, by Application

  • 8.1. Introduction
  • 8.2. In-Vitro Diagnostics
  • 8.3. Pharmaceutical & Life Science Research
  • 8.4. Therapeutics

9. Microfluidics Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals & Diagnostic Centers
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Microfluidics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Microfluidics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Microfluidics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Astraveus Raises €16.5 Million Series Seed Round to Advance the Development of its Automated, Microfluidic Cell and Gene Therapy Manufacturing Platform
    • 13.3.2. Bio-Techne to acquire Swiss spatial biology firm Lunaphore
    • 13.3.3. CellFE Announces Launch of Novel Microfluidic Cellular Engineering Platform at ASGCT 2023 Annual Meeting

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. MICROFLUIDICS MARKET RESEARCH PROCESS
  • FIGURE 2. MICROFLUIDICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MICROFLUIDICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MICROFLUIDICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL MICROFLUIDICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. MICROFLUIDICS MARKET DYNAMICS
  • FIGURE 7. GLOBAL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL MICROFLUIDICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL MICROFLUIDICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES MICROFLUIDICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES MICROFLUIDICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. MICROFLUIDICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. MICROFLUIDICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MICROFLUIDICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MICROFLUIDICS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL MICROFLUIDICS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL MICROFLUIDICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL MICROFLUIDICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL MICROFLUIDICS MARKET SIZE, BY GLASS-BASED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL MICROFLUIDICS MARKET SIZE, BY GLASS-BASED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL MICROFLUIDICS MARKET SIZE, BY POLYMER-BASED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL MICROFLUIDICS MARKET SIZE, BY POLYMER-BASED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL MICROFLUIDICS MARKET SIZE, BY SILICON-BASED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL MICROFLUIDICS MARKET SIZE, BY SILICON-BASED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICRO NEEDLE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICRO NEEDLE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICRO PUMP, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICRO PUMP, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICROFLUIDIC CHIP, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICROFLUIDIC CHIP, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL MICROFLUIDICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL MICROFLUIDICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL MICROFLUIDICS MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL MICROFLUIDICS MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL MICROFLUIDICS MARKET SIZE, BY VETERINARY DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL MICROFLUIDICS MARKET SIZE, BY VETERINARY DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL MICROFLUIDICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL MICROFLUIDICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL MICROFLUIDICS MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL MICROFLUIDICS MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL MICROFLUIDICS MARKET SIZE, BY GENOMIC ANALYSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL MICROFLUIDICS MARKET SIZE, BY GENOMIC ANALYSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL MICROFLUIDICS MARKET SIZE, BY PROTEOMIC ANALYSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL MICROFLUIDICS MARKET SIZE, BY PROTEOMIC ANALYSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICRODISPENSING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICRODISPENSING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICROREACTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICROREACTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL MICROFLUIDICS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL MICROFLUIDICS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL MICROFLUIDICS MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL MICROFLUIDICS MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL MICROFLUIDICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL MICROFLUIDICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL MICROFLUIDICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL MICROFLUIDICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL MICROFLUIDICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 79. AMERICAS MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2023 (USD MILLION)
  • TABLE 80. AMERICAS MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2024-2030 (USD MILLION)
  • TABLE 83. AMERICAS MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 84. AMERICAS MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 85. AMERICAS MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 86. AMERICAS MICROFLUIDICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 87. AMERICAS MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 88. AMERICAS MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 89. ARGENTINA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 90. ARGENTINA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 91. ARGENTINA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 92. ARGENTINA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 93. ARGENTINA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. ARGENTINA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. ARGENTINA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 96. ARGENTINA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 97. ARGENTINA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2023 (USD MILLION)
  • TABLE 98. ARGENTINA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2024-2030 (USD MILLION)
  • TABLE 99. ARGENTINA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2023 (USD MILLION)
  • TABLE 100. ARGENTINA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2024-2030 (USD MILLION)
  • TABLE 101. ARGENTINA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 102. ARGENTINA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 103. ARGENTINA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 104. ARGENTINA MICROFLUIDICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 105. BRAZIL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 106. BRAZIL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 107. BRAZIL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 108. BRAZIL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 109. BRAZIL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. BRAZIL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. BRAZIL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 112. BRAZIL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 113. BRAZIL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2023 (USD MILLION)
  • TABLE 114. BRAZIL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2024-2030 (USD MILLION)
  • TABLE 115. BRAZIL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2023 (USD MILLION)
  • TABLE 116. BRAZIL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2024-2030 (USD MILLION)
  • TABLE 117. BRAZIL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 118. BRAZIL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 119. BRAZIL MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 120. BRAZIL MICROFLUIDICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 121. CANADA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 122. CANADA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 123. CANADA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 124. CANADA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 125. CANADA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 126. CANADA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 127. CANADA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 128. CANADA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 129. CANADA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2023 (USD MILLION)
  • TABLE 130. CANADA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2024-2030 (USD MILLION)
  • TABLE 131. CANADA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2023 (USD MILLION)
  • TABLE 132. CANADA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2024-2030 (USD MILLION)
  • TABLE 133. CANADA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 134. CANADA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 135. CANADA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 136. CANADA MICROFLUIDICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 137. MEXICO MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 138. MEXICO MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 139. MEXICO MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 140. MEXICO MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 141. MEXICO MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. MEXICO MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. MEXICO MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 144. MEXICO MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 145. MEXICO MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2023 (USD MILLION)
  • TABLE 146. MEXICO MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2024-2030 (USD MILLION)
  • TABLE 147. MEXICO MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2023 (USD MILLION)
  • TABLE 148. MEXICO MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2024-2030 (USD MILLION)
  • TABLE 149. MEXICO MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 150. MEXICO MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 151. MEXICO MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 152. MEXICO MICROFLUIDICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 153. UNITED STATES MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 154. UNITED STATES MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 155. UNITED STATES MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 156. UNITED STATES MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 157. UNITED STATES MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. UNITED STATES MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. UNITED STATES MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 160. UNITED STATES MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 161. UNITED STATES MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2023 (USD MILLION)
  • TABLE 162. UNITED STATES MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2024-2030 (USD MILLION)
  • TABLE 163. UNITED STATES MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2023 (USD MILLION)
  • TABLE 164. UNITED STATES MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2024-2030 (USD MILLION)
  • TABLE 165. UNITED STATES MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 166. UNITED STATES MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 167. UNITED STATES MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 168. UNITED STATES MICROFLUIDICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 169. UNITED STATES MICROFLUIDICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 170. UNITED STATES MICROFLUIDICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2023 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2024-2030 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2023 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2024-2030 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 189. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 190. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 191. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 192. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 193. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 196. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 197. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2023 (USD MILLION)
  • TABLE 198. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2024-2030 (USD MILLION)
  • TABLE 199. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2023 (USD MILLION)
  • TABLE 200. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2024-2030 (USD MILLION)
  • TABLE 201. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 202. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 203. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 204. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 205. CHINA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 206. CHINA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 207. CHINA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 208. CHINA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 209. CHINA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. CHINA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. CHINA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 212. CHINA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 213. CHINA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2023 (USD MILLION)
  • TABLE 214. CHINA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2024-2030 (USD MILLION)
  • TABLE 215. CHINA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2023 (USD MILLION)
  • TABLE 216. CHINA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2024-2030 (USD MILLION)
  • TABLE 217. CHINA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 218. CHINA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 219. CHINA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 220. CHINA MICROFLUIDICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 221. INDIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 222. INDIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 223. INDIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 224. INDIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 225. INDIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. INDIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. INDIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 228. INDIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 229. INDIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2023 (USD MILLION)
  • TABLE 230. INDIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2024-2030 (USD MILLION)
  • TABLE 231. INDIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2023 (USD MILLION)
  • TABLE 232. INDIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2024-2030 (USD MILLION)
  • TABLE 233. INDIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 234. INDIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 235. INDIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 236. INDIA MICROFLUIDICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 237. INDONESIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 238. INDONESIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 239. INDONESIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 240. INDONESIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 241. INDONESIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. INDONESIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. INDONESIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 244. INDONESIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 245. INDONESIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2023 (USD MILLION)
  • TABLE 246. INDONESIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2024-2030 (USD MILLION)
  • TABLE 247. INDONESIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2023 (USD MILLION)
  • TABLE 248. INDONESIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2024-2030 (USD MILLION)
  • TABLE 249. INDONESIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 250. INDONESIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 251. INDONESIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 252. INDONESIA MICROFLUIDICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 253. JAPAN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 254. JAPAN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 255. JAPAN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 256. JAPAN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 257. JAPAN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. JAPAN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. JAPAN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 260. JAPAN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 261. JAPAN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2023 (USD MILLION)
  • TABLE 262. JAPAN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2024-2030 (USD MILLION)
  • TABLE 263. JAPAN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2023 (USD MILLION)
  • TABLE 264. JAPAN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2024-2030 (USD MILLION)
  • TABLE 265. JAPAN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 266. JAPAN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 267. JAPAN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 268. JAPAN MICROFLUIDICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 269. MALAYSIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 270. MALAYSIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 271. MALAYSIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 272. MALAYSIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 273. MALAYSIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 274. MALAYSIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 275. MALAYSIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 276. MALAYSIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 277. MALAYSIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2023 (USD MILLION)
  • TABLE 278. MALAYSIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2024-2030 (USD MILLION)
  • TABLE 279. MALAYSIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2023 (USD MILLION)
  • TABLE 280. MALAYSIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2024-2030 (USD MILLION)
  • TABLE 281. MALAYSIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 282. MALAYSIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 283. MALAYSIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 284. MALAYSIA MICROFLUIDICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 285. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 286. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 287. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 288. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 289. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 290. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 291. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 292. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 293. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2023 (USD MILLION)
  • TABLE 294. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2024-2030 (USD MILLION)
  • TABLE 295. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2023 (USD MILLION)
  • TABLE 296. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2024-2030 (USD MILLION)
  • TABLE 297. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 298. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 299. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 300. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 301. SINGAPORE MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 302. SINGAPORE MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 303. SINGAPORE MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 304. SINGAPORE MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 305. SINGAPORE MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 306. SINGAPORE MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 307. SINGAPORE MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 308. SINGAPORE MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 309. SINGAPORE MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2023 (USD MILLION)
  • TABLE 310. SINGAPORE MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2024-2030 (USD MILLION)
  • TABLE 311. SINGAPORE MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2023 (USD MILLION)
  • TABLE 312. SINGAPORE MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2024-2030 (USD MILLION)
  • TABLE 313. SINGAPORE MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 314. SINGAPORE MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 315. SINGAPORE MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 316. SINGAPORE MICROFLUIDICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 317. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 318. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 319. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 320. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 321. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 322. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 323. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 324. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 325. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2023 (USD MILLION)
  • TABLE 326. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2024-2030 (USD MILLION)
  • TABLE 327. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2023 (USD MILLION)
  • TABLE 328. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2024-2030 (USD MILLION)
  • TABLE 329. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 330. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 331. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 332. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 333. TAIWAN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 334. TAIWAN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 335. TAIWAN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 336. TAIWAN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 337. TAIWAN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 338. TAIWAN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 339. TAIWAN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 340. TAIWAN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 341. TAIWAN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2023 (USD MILLION)
  • TABLE 342. TAIWAN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2024-2030 (USD MILLION)
  • TABLE 343. TAIWAN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2023 (USD MILLION)
  • TABLE 344. TAIWAN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2024-2030 (USD MILLION)
  • TABLE 345. TAIWAN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 346. TAIWAN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 347. TAIWAN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 348. TAIWAN MICROFLUIDICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 349. THAILAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 350. THAILAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 351. THAILAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 352. THAILAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 353. THAILAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 354. THAILAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 355. THAILAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 356. THAILAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 357. THAILAND MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESE